Making Sense of the Marijuana Stock Armageddon

The Hexo stock and Village Farms stock are exhibiting the extreme volatility of marijuana stocks. Both cannabis producers were unable to sustain momentum because of disappointing earnings results and mounting losses.

| More on:
Businessman holding tablet and showing a growing virtual hologram of statistics, graph and chart with arrow up on dark background. Stock market. Business growth, planning and strategy concept

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

In the ailing marijuana industry, the future is not as bright as the earlier projections. Indeed, we’re witnessing an Armageddon instead of a deterrent against the black market.

The economic benefits of the legal marijuana market are huge and could be worth US$57 billion worldwide. After its legalization, however, it became a bloodbath for cannabis companies. Market values have been dropping like crazy since April.

Hexo (TSX:HEXO)(NYSE:HEXO), for example, was a high flyer, peaking to $11.11 to end April. As of this writing, the stock is down to $3.11 — or a sharp drop of 257%.

Village Farms (TSX:VFF)(NASDAQ:VFF) is up 146% year to date, although it was also a victim of the carnage. The stock rose to as high as $23.34 toward the latter part of March, only to lose steam just the same.

Beaten down

Many investors bailed out from Hexo because of the terrible losses. The stock rode the marijuana hype and flew high. From a $2.4 billion market cap in early June, it’s down to $755.56 million this October.

Still, Hexo enjoys the upper hand in the long-term because of the supply agreements with five Canadian provinces. The landmark deal is the five-year contract with Quebec that could translate to over $1 billion in revenue.

Hexo is also hoping to make a splash in the European continent with its partnership with a prominent cannabis operator in Greece. The partners are building a 350 square feet licensed facility that will serve as the distribution hub of its cannabis-derived products and supply branded product lines to all markets in Europe.

Finally, the partnership with Molson Coors Brewing should give Hexo a strong position in Cannabis 2.0, particularly in the cannabis-infused beverage market.

Slow ascent

While Village Farms is not as beaten down as Hexo, the struggle continues. One thing going for this $571.7 million cannabis producer is its inclusion in the flagship program known as the TSX 30. The company ranks number three on the list because of its over 868% total return in the last three years.

According to CEO and Founder of Village Farms Michael DeGiglio, the company is leveraging more than three decades as a leader in large-scale, precision agriculture. The goal is to add cannabis and the CBD markets to its legacy produce business.

Village Farms is beginning to realize the value of the significant new growth opportunities in the cannabis space. Management believes the earning potentials in both the near and long-term is incredible. It’s anchoring its success on the 50%-owned joint venture with Pure Sunfarms.

The JV is for a large-scale, low-cost, high-quality cannabis production in Canada. Village Farms’ has the potential to double capacity with two greenhouses and the option to build a third.

Preposterous forecasts

Despite the bloodbath, analysts are forecasting the prices of Hexo and Village Farms to climb 302% and 285%, respectively, in the next 12 months.

If you have the stomach for extreme volatility, you can buy into the unbelievable estimates. Otherwise, stay clear of marijuana stocks until the industry stabilizes.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool owns shares of Molson Coors Brewing and Village Farms International, Inc.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »